- Open Access
Protective effect of resin adsorption on septic plasma-induced tubular injury
Critical Care volume 14, Article number: R4 (2010)
A pro-apoptotic effect of circulating mediators on renal tubular epithelial cells has been involved in the pathogenesis of sepsis-associated acute kidney injury (AKI). Adsorption techniques have been showed to efficiently remove inflammatory cytokines from plasma. The aim of this study was to evaluate the efficiency of the hydrophobic resin Amberchrom CG161 M to adsorb from septic plasma soluble mediators involved in tubular injury.
We enrolled in the study 10 critically ill patients with sepsis-associated AKI and we evaluated the effects of their plasma on granulocyte adhesion, apoptosis and functional alterations of cultured human kidney tubular epithelial cells. We established an in vitro model of plasma adsorption and we studied the protective effect of unselective removal of soluble mediators by the Amberchrom CG161 M resin on septic plasma-induced tubular cell injury.
Plasma from septic patients induced granulocyte adhesion, apoptosis and altered polarity in tubular cells. Plasma adsorption significantly decreased these effects and abated the concentrations of several soluble mediators. The inhibition of granulocyte adhesion to tubular cells was associated with the down-regulation of ICAM-1 and CD40. Resin adsorption inhibited tubular cell apoptosis induced by septic plasma by down-regulating the activation of caspase-3, 8, 9 and of Fas/death receptor-mediated signalling pathways. The alteration of cell polarity, morphogenesis, protein reabsorption and the down-regulation of the tight junction molecule ZO-1, of the sodium transporter NHE3, of the glucose transporter GLUT-2 and of the endocytic receptor megalin all induced by septic plasma were significantly reduced by resin adsorption.
Septic plasma induced a direct injury of tubular cells by favouring granulocyte adhesion, by inducing cell apoptosis and by altering cell polarity and function. All these biological effects are related to the presence of circulating inflammatory mediators that can be efficiently removed by resin adsorption with a consequent limitation of tubular cell injury.
The incidence of acute kidney injury (AKI) has considerably increased during the past few years [1, 2]. AKI is a frequent complication occurring in critically ill patients with sepsis or septic shock [3–5]. The mechanisms of sepsis-induced tissue injury are complex and seem to be related not only to the ischemic response to hypoperfusion, but also to a direct detrimental activity induced by circulating mediators with both pro- and anti-inflammatory properties able to interact in a dynamic manner and to induce multiple organ failure [5, 6].
We recently showed that plasma derived from septic patients with severe burns induced apoptosis and functional alterations of glomerular podocytes and tubular epithelial cells (TEC) . These data confirmed the observations coming from different studies showing that inflammatory cytokines and lipopolysaccharides (LPS) activated the apoptotic pathways in tubular cells via caspase activation and Fas up-regulation [8–10]. In addition, in experimental animal models of sepsis, a broad range of functional alterations of tubular re-absorption such as sodium, urea and glucose renal transporter dysfunction has been reported in the presence of an inflammatory microenvironment [11–13]. Taken together, these data support the hypothesis of a prominent role of circulating mediators in the pathogenesis of sepsis-related AKI.
Renal replacement therapy (RRT) is an important therapeutic strategy in patients with AKI. Several studies suggested that RRT is able to maintain adequate fluid, electrolyte and acid-base balance but can also favorably influence the outcome of AKI patients by removing a broad range of inflammatory substances [14–16]. Various mechanisms have been proposed for such removal: diffusion, convection and adsorption . Indeed, the adsorption matrixes may be useful tools to remove different inflammatory mediators by non-selective simultaneous adsorption [18, 19]. Based on previous studies, Amberchrom CG161 M, a rigid, highly cross-linked microreticular hydrophobic adsorbent polymer was chosen as having the most convenient particle and pore size .
The aim of this study was to establish an in vitro model of tubular injury based on the effects of septic plasma and to evaluate whether the unselective removal of circulating plasma factors by the Amberchrom resin could be protective on septic plasma-induced tubular cell injury.
Materials and methods
From June to December 2008, 10 critically ill patients (mean age: 63.9 ± 11.2 years; gender: seven males, three females) admitted to the intensive care unit (ICU) of the San Bortolo Hospital in Vicenza, Italy, were enrolled in the study. Inclusion criteria were: the presence of septic shock in accordance to the criteria defined by the American College of Chest Physicians and by the Society of Critical Care Medicine ; and the presence of AKI determined by the evaluation of serum creatinine or urinary output (inclusion in the failure group of RIFLE criteria) [22, 23]. Exclusion criteria were: age younger than 18 years, solid organ or bone marrow transplantation, hemorrhagic dysfunction, thrombophilia, chronic renal failure, glomerulonephritis or collagenopathies. The severity of illness was assessed by Sequential Organ Failure Assessment (SOFA) score at the moment of ICU admission and at the start of the dialytic treatment. As control, plasma was obtained from five healthy volunteers. Informed consent was obtained according to the Declaration of Helsinki and the study was authorized by the Internal Review Board of the San Bortolo Hospital.
In vitro plasma adsorption: experimental design
The Amberchrom CG161 M resin (Rohm and Haas Company, Philadelphia, PA, USA). was activated in 50% methanol and extensively washed in isotonic saline. Two ml of the resin were packed into chromatography columns with an inner diameter of 1 cm (Biorad, Hercules, CA, USA). Prior to filling with the resin, columns were treated with silane (Sigma, St. Louis, MO, USA). The resin beds were perfused with a solution of 4% human serum albumin in PBS containing a cocktail of recombinant cytokines at the following concentrations (pg/ml): TNF-α (600), IL-1β (200), IL-10 (350), IL-8 (400), and IL-6 (300). For IL-1β, an additional series of experiments was carried out using 1 ml of adsorbent and an IL-1β spike concentration of 300 pg/ml. The flow rate was set to 0.3 ml/min corresponding to a linear velocity of 22 cm/h. Fractions of 2 ml were collected and stored at -80°C until assayed (see below). Before in vitro tests on tubular cells, the Amberchrom CG161 M resin was extensively washed by isotonic saline and then mixed with plasma collected from patients with sepsis-related AKI (90% volume plasma + 10% volume Amberchrom CG161 M resin). Plasma/resin mixture was kept in a condition of slight agitation at 37°C for 120 minutes. Samples were taken in sterile conditions after 15, 30, 60 and 120 minutes of agitation. At the start and at the end of adsorption, plasmatic levels of TNF-α, Fas-Ligand (Fas-L) and CD40-Ligand (CD40-L or CD154) were determined by ELISA (R&D Systems, Minneapolis, MN, USA). Results were calculated after generation of a standard curve with appropriate controls and given as averages ± standard deviation (SD).
Isolation and characterization of human proximal tubular epithelial cells and umbilical vein endothelial cells
Primary cultures of human proximal TEC were obtained from kidneys removed by surgical procedures from patients affected by renal carcinomas as previously described . Primary TEC were immortalized by infection with a hybrid Adeno5/SV40 virus  and cultured with RPMI 1640 (GIBCO, Grand Island, NY, USA) containing 10% FCS (Hyclone, Logan, UT, USA) and 2 mM glutamine (GIBCO, Grand Island, NY, USA). The purity of TEC cultures was assessed on the basis of cell characterization, according to published criteria [24, 25]. Human umbilical vein endothelial cells (HUVEC) were isolated and characterized as previously described .
Adhesion of polymorphonuclear neutrophils to TEC or HUVEC monolayers
Polymorphonuclear neutrophils (PMN) were isolated from blood of healthy volunteers by density centrifugation as previously described  and labeled overnight with 10 μM Vybrant Cell Tracer kit (Invitrogen, San Diego, CA, USA) according to the manufacturer's instructions in RPMI and 10% FBS. Labeled cells were counted, resuspended to 50 × 106/ml RPMI and added to a confluent monolayer of TEC or HUVEC cultured on six-well plates and previously incubated with different plasma samples. Experiments were carried out in triplicate for one hour at 37°C in conditions of slight agitation. At the end of incubation, plates were filled with medium and aspirated three times to remove unbound cells. All samples were fixed with 1% paraformaldehyde and observed under a UV light microscope. Green fluorescent cells were counted on 10 different fields at ×100 magnification.
TEC were cultured on 24-well plates (Falcon Labware, Oxnard, CA, USA) at a concentration of 5 × 104 cells/well and incubated with different plasma concentrations and 250 μg/ml XTT (Sigma, St. Louis, MO, USA) in a medium lacking phenol red. The absorption values at 450 nm were measured in an automated spectrophotometer at different time points. All experiments were performed in triplicate.
Detection of apoptosis
TEC were incubated with different plasma and then subjected to terminal deoxynucleotidyltransferase-mediated dUTP nick end labelling (TUNEL) assay (ApopTag, Oncor, Gaithersburg, MD, USA) that identifies DNA fragmentation, a typical feature of apoptotic cells. Green-stained apoptotic cells were counted in different microscopic fields at ×100 magnification. In selected experiments, LPS (30 ng/ml) (Sigma, St. Louis, MO, USA), polymyxin B (5 μg/ml) (Sigma, St. Louis, MO, USA), TNF-α (20 ng/ml) (Sigma, St. Louis, MO, USA) and interferon (IFN)-γ (20 ng/ml) (Sigma, St. Louis, MO, USA) were used.
Propidium iodide nuclear staining
Propidium iodide nuclear staining was used to identify DNA fragmentation, a typical feature of apoptotic cells. TEC were cytospinned, fixed with 1% paraformaldehyde and stained by a solution containing 50 μg/ml propidum iodide (Sigma, St. Louis, MO, USA), 0.1% sodium citrate (Sigma, St. Louis, MO, USA), 0.1% Triton-X-100 (Sigma, St. Louis, MO, USA) and 20 μg/ml DNase-free RNase (Sigma, St. Louis, MO, USA) diluted in sterile water. All samples were examined by UV light microscopy.
Generation of transfectants and RNA interference
Chinese hamster ovary (CHO) transfectants were generated by electroporation with plasmid vectors containing cDNA coding for a soluble form of Fas-L, CD40-L (gp39-CD8) or with control empty vectors (mock) at 250 V and 960 μF in 4 mm electroporation cuvettes in an electroporator II (Invitrogen, San Diego, CA, USA). Clones were selected for 1 mg/ml G418 resistance in RPMI 1640 plus 10% FCS. After selection, supernatants were collected and used for in vitro tests on TEC.
In selected experiments TEC were seeded on six-well plates and TNF-receptor (R) 1, Fas, CD40 siRNA or relative control siRNA (80 pM) was introduced according to manufacturer's instructions (Santa Cruz Biotech, Santa Cruz, CA, USA). After 48 hours, the effective suppression of specific mRNAs and proteins was verified by RT-PCR and by immunofluorescence or western blot analysis. Subsequently, engineered cells were used to evaluate plasma-induced apoptosis and PMN adhesion.
Caspases-3, -8 and -9 activity
The activity of caspase-3, -8 and -9 was assessed by a colorimetric assay (Chemicon Int., Temecula, CA, USA) based on the spectrophotometric detection of the cromophore p-nitroanilide (pNA) after cleavage from the labelled substrate DEVD-pNA by caspases . Each experiment was performed in triplicate. Results are given as average of percentage increase of caspase activity in respect to incubation with control healthy plasma ± SD.
Analysis of transepithelial electrical resistance
Transepithelial electrical resistance (TER) was used as an indicator of TEC polarity. Cells were plated in transwells on collagen-coated polycarbonate membranes (Corning Costar Corp., Cambridge, MA, USA) and allowed to reach confluence before the addition of different plasma samples. An epithelial volt-ohm meter (EVOM; World Precision Instruments, Inc., Sarasota, FL, USA) was used to determine TER values as previously described . All measures were performed in triplicate and normalized for the area of the membrane.
Tubular adhesion to extracellular matrixes and morphogenesis assay
Adhesion of TEC to extracellular matrixes was evaluated on 24-well culture plates previously coated for six hours with 20 μg/ml of human fibronectin/type IV collagen or Matrigel (Becton Dickinson, Franklin Lakes, NJ, USA). Non-specific adhesion was blocked by incubation for two hours with 2% BSA diluted in one times PBS. TEC were exposed to different plasma for six hours at 37°C in conditions of slight agitation. Thereafter, aliquots of stimulated cells were added to the wells and allowed to adhere for two hours at 37°C. Supernatants were then removed and attached cells were subjected to the XTT-based assay as reported above. For morphogenesis studies, TEC were cultured on Matrigel-coated plates for 72 hours and in the presence of control healthy or septic plasmas.
Detection of FITC-conjugated albumin uptake
Albumin uptake was studied after incubation of TEC previously exposed to different plasma with 50 mg/ml of FITC-conjugated human albumin (Sigma, St. Louis, MO, USA) at 37°C for two hours. After FITC-albumin challenge, TEC were extensively washed twice with ice-cold one times PBS and analysed by FACS and confocal microscopy after co-staining with an antibody directed to megalin (see below).
After appropriate stimuli, cultured TEC were fixed in ethanol/acetic acid 2:1 and stained with antibodies directed to human Fas (Upstate Biotechnology, Lake Placid, NY, USA), zonula occludens-1 (ZO-1), megalin, proximal tubular sodium transporter sodium-hydrogen exchanger-3 (NHE3) and glucose transporter 2 (GLUT-2; Santa Cruz Biotech, Santa Cruz, CA, USA). After incubation with primary antibodies, samples were washed with one times PBS and incubated with appropriated Alexa Fluor-conjugated secondary antibodies (Molecular Probes, Carlsbad, CA, USA) for 30 minutes, room temperature when needed. All samples were counterstained by 1 μg/ml propidium iodide or 0.5 μg/ml Hoechst for 30 seconds, mounted with anti-fade mounting medium (Vector Laboratories, Burlingame, CA, USA) and examined by confocal microscopy.
For FACS analysis, after exposure to different plasmas, TEC were detached from tissue culture plates with EDTA, washed twice with one times PBS and stained for one hour at 4°C with FITC-conjugated antibodies directed to human Fas, CD40, inter-cellular adhesion molecule-1 (ICAM-1) (Becton Dickinson, Franklin Lakes, NJ, USA) or with an irrelevant control antibody. All incubation periods were performed using a medium containing 0.25% BSA and 0.0016% sodium azide. At the end of staining, cells were newly washed, fixed in 1% paraformaldehyde and subjected to FACS analysis (Becton Dickinson, Franklin Lakes, NJ, USA).
All data of different experimental procedures are expressed as average ± SD. Statistical analysis was performed by analysis of variance with Newmann-Keuls multicomparison test or Student's t- test where appropriated. The P values less than 0.05 were considered as the threshold for significance.
Selected patients with sepsis-associated AKI showed an average SOFA score of 13.4 ± 7.1 at the start of the dialytic treatment. AKI was detected by the rise of serum creatinine (3.3 ± 1.6 mg/dl) and urea (146 ± 84.7 mg/dl). All patients were included in the failure group of RIFLE criteria .
Effect of plasma adsorption on PMN-TEC and PMN-HUVEC interaction
Septic plasma induced an increased expression of the costimulatory molecule CD40 and of the adhesion receptor ICAM-1 on TEC surface (Figure 1a), molecules that are both deeply involved in the PMN-TEC interaction . Septic plasma induced a significant increase of PMN adhesion to TEC and to HUVEC in comparison to healthy plasma (Figures 1b and 1c). Plasma adsorption with Amberchrom resin significantly inhibited PMN adhesion on both cell types (Figures 1b and 1c). The decreased expression of ICAM-1 and in particular of CD40 on TEC could account for the reduced PMN adhesion. Indeed, pre-adsorption of septic plasma with Amberchrom resin inhibited the increased TEC expression of CD40 and ICAM-1 (Figure 1a). Moreover, PMN adhesion was increased after incubation of TEC with supernatants of CHO cells transfected with a cDNA coding for a soluble form of CD154 (CD40L), but not with an empty vector (Figure 1d). In addition, a significant decrease of septic plasma-induced PMN adhesion was observed when TEC were transfected by CD40 siRNA but not by control siRNA (Figure 1d).
Effect of plasma adsorption on TEC apoptosis and cytokine levels
Increasing concentrations of plasma derived from patients with sepsis-related AKI induced a significant cytotoxic effect on cultured TEC, as detected by the XTT-based assay after 48 hours incubation (Figure 2a). The cytotoxic effect was absent when TEC were cultured with plasma of healthy volunteers. Septic plasma-induced TEC toxicity was detected after 12 hours incubation and remained significantly higher after 24 and 48 hours with an average 50 to 60% decrease of TEC viability (Figure 2b). In contrast, incubation of TEC with plasma obtained after Amberchrom resin adsorption showed a significant reduction of their cytotoxic activity on TEC at all time points considered (Figure 2b). The cytotoxic effect exerted by septic plasma on TEC was ascribed to the apoptotic cascade pathway. Indeed, as showed by TUNEL assay, exposure of TEC for 48 hours to septic plasma induced a significant increase of apoptosis in respect to healthy plasma (Figure 3a). However, when TEC were cultured for 48 hours in the presence of Amberchrom resin-adsorbed plasma, the apoptotic rate was significantly reduced (Figure 3a). The inhibition of plasma-induced apoptosis was observed after incubation of TEC with samples obtained after 15, 30, 60 and 120 minutes from the beginning of adsorption. The maximal inhibition of plasma-induced apoptosis of TEC was detected with samples obtained after 120 minute adsorption (Figure 3a). LPS (30 ng/ml) was used as a positive control (Figure 3a). Interestingly, the addition in culture of 5 μg/ml polymyxin B significantly reduced but did not completely abolish the pro-apoptotic activity of septic plasma (Figure 3a). These results were confirmed by counting nuclear fragmentation, a typical feature of apoptotic cells, after propidium iodide staining (not shown). Moreover, the pre-incubation with septic plasma induced a significant increase of TEC apoptosis in the presence of LPS and inflammatory cytokines (Figure 3b). This effect was not observed with plasma previously subjected to resin adsorption or with healthy plasma (Figure 3b). In accordance to the TUNEL data, the activities of caspases-3, -8 and -9 were significantly increased in TEC incubated with septic plasma. In contrast, a significant reduction of all caspase activities was observed in TEC cultured in the presence of Amberchrom resin-treated plasma (120 minutes of treatment; Figure 3c). These results suggest that plasma-induced TEC apoptosis was predominantly associated to the activation of the death-receptor pathway induced by soluble mediators. Indeed, the knock-down of TNF-R1, Fas and CD40 in TEC by specific siRNA significantly decreased the pro-apoptotic activity of septic plasma (Figure 4a). We also found that supernatants collected from CHO cells transfected with human Fas-L cDNA induced a significant increase of septic plasma-associated apoptosis (Figure 4b). The apoptotic rate of plasma-treated TEC was not affected by supernatants derived from mock-transfected CHO cells (Figure 4b). These data suggest that septic plasma induced a sensitization of TEC to Fas-mediated apoptosis. Amberchrom resin adsorption abrogated the sensitization of TEC to Fas-mediated apoptosis (Figure 4b). The sensitization of TEC to Fas-mediated apoptosis may be ascribed to the up-regulation of Fas on TEC surface induced by septic plasma that was not observed after Amberchrom resin adsorption (Figures 4c and 4d). In addition, Amberchrom resin adsorption reduced the concentration of pro-apoptotic soluble plasma factors. The high binding capacity of the Amberchrom resin for different inflammatory cytokines was first evaluated in dynamic tests (Table 1). The binding activity of the Amberchrom resin was confirmed by ELISA data on patients' plasma (Figure 5). At study admission, septic patients presented high plasmatic levels of TNF-α, soluble Fas-L and soluble CD40-Ligand (CD154). After 120 minutes absorption by Amberchrom resin, all tested cytokines significantly decreased (Figure 5).
Effect of resin adsorption on functional TEC alterations
Septic plasma significantly reduced TER, an indicator of TEC polarity. This effect was abrogated in the presence of Amberchrom resin-treated plasma (Figure 6a). Further evidence for the maintenance of TEC polarity and function came from the observation that Amberchrom resin abrogated the down-regulation of the tight junction protein ZO-1, proximal tubular cell sodium transporter NHE3 and glucose transporter GLUT-2, which were all induced by septic plasma (Figure 6b). In addition, the reduced adhesion of TEC to the extracellular matrixes fibronectin/type IV collagen and Matrigel observed in the presence of septic plasma was significantly inhibited after Amberchrom resin adsorption (Figure 7a). TEC cultured on Matrigel-coated plates showed a typical morphology characterized by early scattering and branching morphogenesis that was reduced after incubation with septic plasma (Figure 7b). In contrast, TEC morphogenesis was not affected by incubation with Amberchrom-adsorbed plasma (Figure 7b). Moreover, we found that septic plasma induced the down-regulation of the endocytic receptor megalin, a molecule involved in tubular re-adsorption of filtered proteins (Figure 8). The decreased expression of megalin was not observed in the presence of Amberchrom resin-treated plasma (Figure 8). This phenomenon was probably responsible for the preserved ability of TEC to internalize FITC-labeled albumin (Figure 8).
The results of the present study showed that septic plasma induced TEC injury, which was abrogated by non-selective removal from the plasma of factors responsible for PMN-TEC adhesion and for apoptosis and altered polarity of TEC.
The mechanisms responsible for AKI in the course of sepsis are not fully elucidated. It has been hypothesized that inflammatory factors present in the circulation or locally produced by resident kidney cells may have an active role in the pathogenesis of tissue damage [8, 10, 29]. Indeed, patients with AKI have elevated plasmatic levels of inflammatory cytokines and high levels of IL-6 and IL-8 are associated with an increased risk of mortality [30, 31].
In the present study, septic plasma was adsorbed with Amberchrom CG161 M, a rigid, hydrophobic, highly cross-linked microreticular adsorbent polymer. Its high binding capacity depends on the relatively small pore structure (median pore size 150 to 200 Å, exclusion limit 70 kDa) and high internal surface area (900 m2/g). The mean particle size of this polymer is approximately 75 μm, which is convenient for achieving a balance of diffusional access and flow . We performed dynamic tests as confirmation of the high binding capacity of the Amberchrom resin for different inflammatory cytokines present simultaneously at very high concentrations . Although in this study we focused on the cytokine adsorption, one may expect that other proteins can bind to the resin as the hydrophobic polymer exhibits a non-selective affinity with respect to proteins depending on the exposure of interacting domains. However, experimental and clinical evidence has suggested that non-selective removal of molecules in severe sepsis is beneficial [32, 33].
In the very early events of sepsis-induced AKI, the adhesion of PMN to TEC may contribute to the pathogenesis of tissue injury . This process is mediated by adhesion molecules such as CD40 and ICAM-1 that are up-regulated by inflammatory cytokines [35, 36]. Indeed, ICAM-1-deficient mice are protected from experimental sepsis-induced AKI . CD40 also plays a crucial role in the innate response and its inhibition is related to a decrease of mortality in experimental septic models . Moreover, the activation of the CD40/CD154 pathway in TEC induces a pro-fibrotic and pro-inflammatory state [39, 40]. We found that after Amberchrom resin adsorption, septic plasma lost the capacity to up-regulate ICAM-1 and to activate the CD40/CD154 pathway on cultured human TEC. This effect may be ascribed to the removal of soluble CD154 from septic plasma. In the course of sepsis, activated platelets and leukocytes may release high amounts of soluble CD154 from their surface that interacts with the CD40 expressed by TEC and other target cells [41, 42]. In this setting, the removal of soluble CD154 as well as other inflammatory mediators by resin adsorption may lead to the inhibition of PMN adhesion to TEC.
It has been suggested that apoptosis plays a key role in the pathogenetic mechanisms of sepsis-related tissue injury including AKI [5, 7, 43–45]. However, a systematic review of the histopathological findings in septic AKI reported a normal histology in the majority of cases . As apoptosis is a reversible process and apoptotic cells are rapidly removed by phagocytic cells it may be difficult to detect tubular apoptotic cells in the histological specimens.
Tubular injury is not the mere result of renal hypoperfusion or cortico-medullary redistribution of blood flow [5, 47]. A direct toxic effect of circulating or locally-produced inflammatory cytokines and LPS has been postulated as the main cause of sepsis-related AKI [7–10]. We found that TEC apoptosis was induced by incubation with septic plasma through the activation of Fas and caspases. These events were all abrogated following Amberchrom resin adsorption of septic plasma. Indeed, we observed a significant reduction of TNF-α, soluble Fas-L and soluble CD154 in septic plasma after incubation with the Amberchrom resin. The relevance of TNF-α, soluble Fas-L and soluble CD154 in inducing TEC injury was confirmed by the observed decrease of apoptosis in TEC engineered to knock-down Fas, CD40 or TNF-R1 by specific siRNA. These results suggest that the unselective removal of circulating inflammatory substances by Amberchrom resin may be responsible for the inhibited activation of the death receptor-mediated apoptotic pathway in TEC.
With the purpose of evaluating the protective effect of resin adsorption on the extension of sepsis-associated AKI after the initial insult, we performed a set of experiments aimed at evaluating the role of a 'priming activity' of septic plasma on TEC apoptosis. We found that the pre-incubation of tubular cells with septic plasma provoked an additional effect on apoptosis induced by LPS and inflammatory cytokines. This effect was decreased after adsorption of septic plasma by CG161 M resin. These results suggest that plasma adsorption may limit the continued renal injury sustained by these mediators.
Despite their pro-apoptotic effect, inflammatory cytokines are also known to alter actin cytoskeleton distribution and integrin cell-matrix interaction via a nitric oxide-dependent mechanism [48, 49]. These events lead to the shedding of viable or dead cells into the tubular lumen, causing a possible obstruction to urine flow and back-leakage of fluid in the interstitial spaces  associated with alteration of cell polarity, a biological function of epithelial cells essential to maintain a correct electrolyte distribution in distinct fluid-filled compartments . In experimental models of sepsis, a dysfunction at tight junction level in different organs has been observed [52, 53]. Indeed, inflammatory cytokines induce tight junction dysfunction in intestinal, pulmonary and hepatic epithelial cells, an event probably ascribed to an increased inducible nitric oxide synthase activity [54–56]. In addition, it has been shown that during severe inflammation renal sodium, chloride, urea and glucose transporters are significantly down-regulated via a cytokine-dependent mechanism [11–13]. Here we show that Amberchrom resin adsorption inhibited the septic plasma-induced decrease of TER and the down-regulation of the tight junction protein ZO-1, sodium channel NHE3 and glucose transporter GLUT-2. Furthermore, the loss of TEC polarity was associated to a redistribution of molecules typically expressed on the apical or basolateral surface . This effect may be responsible for the decreased adhesion of TEC to extracellular matrixes as well as for the altered morphogenesis. All these biological effects were inhibited by treatment of plasma with the Amberchrom resin, suggesting a protective effect related not only to the inhibition of TEC apoptosis, but also to the preservation of cell polarity and function.
Microalbuminuria is a typical finding in septic patients . Urinary loss of proteins may be related to an increased permeability of the glomerular filtration barrier . However, injured TEC may contribute to proteinuria through the impairment of reabsorption. In this setting, megalin is an endocytic receptor involved in the reabsorption of proteins with different molecular weight, including albumin . Megalin-deficient mice are characterized by the development of low molecular weight proteinuria . We found that plasma from septic patients induced the loss of megalin from TEC and inhibited FITC-labelled albumin reabsorption. Amberchrom resin adsorption prevented the loss of megalin expression and of albumin uptake by TEC induced by septic plasma. These results also indicate a possible protective effect of resin adsorption on the maintenance of protein uptake by injured TEC.
The occurrence and relevance of apoptosis and of increased tubular permeability in human sepsis-associated AKI needs to be further critically evaluated. However, we may hypothesize that plasma circulating in the peritubular capillaries may enhance PMN adhesiveness to endothelial, promote vascular permeability and later induce a direct injury of tubular cells leading to cell apoptosis and altered cell polarity and function. It is reasonable to think that these changes occur at a very early stage after the primary insult.
The results of this study showed that septic plasma induced different injurious effects on cultured TEC by favouring PMN adhesion, inducing cell apoptosis and altering cell polarity and function. All these biological effects are related to the presence of circulating inflammatory mediators that can be efficiently removed by unselective resin adsorption with a consequent limitation of tubular cell injury. Whether non-selective removal of cytokines may have a protective or therapeutic role in human sepsis-associated AKI is an attractive possibility which needs further investigation.
Circulating factors present in plasma of septic patients induce granulocyte adhesion, apoptosis and alter polarity in tubular cells, biological events involved in the pathogenesis of sepsis-associated AKI.
Resin adsorption inhibits septic plasma-induced granulocyte adhesion to endothelial and tubular cells mediated by the adhesion receptor ICAM-1 and by the costimulatory molecule CD40.
Resin adsorption inhibits the apoptosis of tubular cells induced by septic plasma which is dependent on the activation of caspase-3, -8, -9 and of the Fas/death receptor-mediated signalling pathways.
Resin adsorption inhibits the alteration of tubular cell polarity, morphogenesis, protein uptake and the down-regulation of the tight junction molecule ZO-1, of the sodium transporter NHE3, of the glucose transporter GLUT-2 and of the endocytic receptor megalin all induced by septic plasma.
The inhibition of septic plasma induced-tubular cell injury after resin adsorption is associated with the decrease of soluble mediators involved in inflammation and apoptosis such as TNF-α, Fas-L and CD40-L.
acute kidney injury
bovine serum albumin
chinese hamster ovary
enzyme-linked immunosorbent assay
fetal calf serum
human umbilical vein endothelial cells
inter-cellular adhesion molecule-1
intensive care unit
renal replacement therapy
reverse-transcription polymerase chain reaction
Sequential Organ Failure Assessment
tubular epithelial cells
trans-epithelial electrical resistance
tumor necrosis factor-α
tumor necrosis factor receptor 1
Cruz DN, Ronco C: Acute kidney injury in the intensive care unit: current trends in incidence and outcome. Crit Care 2007, 11: 149. 10.1186/cc5965
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8: R204-R212. 10.1186/cc2872
Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004, 351: 159-169. 10.1056/NEJMra032401
Lopez JA, Jorge S, Resina C, Santos C, Pereira A, Neves J, Antunes F, Prata MM: Prognostic utility of RIFLE for acute renal failure in patients with sepsis. Crit Care 2007, 11: 408. 10.1186/cc5722
Wan L, Bellomo R, Di Giantomasso D, Ronco C: The pathogenesis of septic acute renal failure. Curr Opin Crit Care 2003, 9: 496-502. 10.1097/00075198-200312000-00006
Klenzak J, Himmelfarb J: Sepsis and the kidney. Crit Care Clin 2005, 21: 211-222. 10.1016/j.ccc.2005.01.002
Mariano F, Cantaluppi V, Stella M, Romanazzi GM, Assenzio B, Cairo M, Biancone L, Triolo G, Ranieri VM, Camussi G: Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 2008, 12: R42. 10.1186/cc6848
Jo SK, Cha DR, Cho WY, Kim HK, Chang KH, Yun SY, Won NH: Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells. Nephron 2002, 91: 406-415. 10.1159/000064280
Guo R, Wang Y, Minto AW, Quigg RJ, Cunningham PN: Acute renal failure in endotoxemia is dependent on caspase activation. J Am Soc Nephrol 2004, 15: 3093-3102. 10.1097/01.ASN.0000145530.73247.F5
Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002, 168: 5817-5823.
Schmidt C, Höcherl K, Schweda F, Kurtz A, Bucher M: Regulation of renal sodium transporters during severe inflammation. J Am Soc Nephrol 2007, 18: 1072-1083. 10.1681/ASN.2006050454
Schmidt C, Höcherl K, Bucher M: Cytokine-mediated regulation of urea transporters during experimental endotoxemia. Am J Physiol Renal Physiol 2007, 292: F1479-F1489. 10.1152/ajprenal.00460.2006
Schmidt C, Höcherl K, Bucher M: Regulation of renal glucose transporters during severe inflammation. Am J Physiol Renal Physiol 2007, 292: F804-F811. 10.1152/ajprenal.00258.2006
Mariano F, Tetta C, Guida G, Triolo G, Camussi G: Hemofiltration reduces the serum priming activity on neutrophil chemiluminescence in septic patients. Kidney Int 2001, 60: 1598-1605. 10.1046/j.1523-1755.2001.00974.x
Sander A, Armbruster W, Sander B, Daul AE, Lange R, Peters J: Haemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 1997, 23: 878-884. 10.1007/s001340050425
De Vriese AS, Colardyn FA, Philippé JJ, Vanholder RC, De Sutter JH, Lameire NH: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10: 846-853.
Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR: Diffusive vs. convective therapy: effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26: 1995-2000. 10.1097/00003246-199812000-00027
Cruz D, Bellomo R, Kellum JA, de Cal M, Ronco C: The future of extracorporeal support. Crit Care Med 2008, 36: S243-S252. 10.1097/CCM.0b013e318168e4f6
Kellum JA, Song M, Venkataraman R: Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004, 32: 801-805. 10.1097/01.CCM.0000114997.39857.69
Tetta C, Cavaillon JM, Schulze M, Ronco C, Ghezzi PM, Camussi G, Serra AM, Curti F, Lonnemann G: Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol Dial Transplant 1998, 13: 1458-1464. 10.1093/ndt/13.6.1458
American College of Chest Physicians Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20: 864-875.
Hoste EA, Kellum JA: Rifle criteria provide robust assessment of kidney dysfunction and correlate with hospital mortality. Crit Care Med 2006, 34: 2016-2017. 10.1097/01.CCM.0000219374.43963.B5
Bellomo R, Kellum JA, Ronco C: Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 2007, 33: 409-413. 10.1007/s00134-006-0478-x
Cantaluppi V, Biancone L, Romanazzi GM, Figliolini F, Beltramo S, Galimi F, Camboni MG, Deriu E, Conaldi P, Bottelli A, Orlandi V, Herrera MB, Pacitti A, Segoloni GP, Camussi G: Macrophage stimulating protein may promote tubular regeneration after acute injury. J Am Soc Nephrol 2008, 19: 1904-1918. 10.1681/ASN.2007111209
Conaldi PG, Biancone L, Bottelli A, Wade-Evans A, Racusen LC, Boccellino M, Orlandi V, Serra C, Camussi G, Toniolo A: HIV-1 kills renal tubular epithelial cells in vitro by triggering an apoptotic pathway involving caspase activation and Fas upregulation. J Clin Invest 1998, 102: 2041-2049. 10.1172/JCI3480
Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B, Camussi G: Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007, 110: 2440-2448. 10.1182/blood-2007-03-078709
Montrucchio G, Lupia E, De Martino A, Silvestro L, Savu SR, Cacace G, De Filippi PG, Emanuelli G, Camussi G: Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-selectin. Circulation 1996, 93: 2152-2160.
Bijuklic K, Sturn DH, Jennings P, Kountchev J, Pfaller W, Wiedermann CJ, Patsch JR, Joannidis M: Mechanisms of neutrophil transmigration across renal proximal tubular HK-2 cells. Cell Physiol Biochem 2006, 17: 233-244. 10.1159/000094128
Camussi G, Biancone L, Iorio EL, Silvestro L, Da Col R, Capasso C, Rossano F, Servillo L, Balestrieri C, Tufano MA: Porins and lypopolysaccharide stimulate platelet activating factor synthesis by human mesangial cells. Kidney Int 1992, 42: 1309-1318. 10.1038/ki.1992.422
Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d'Intini V, Bellomo R: Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003, 27: 792-801. 10.1046/j.1525-1594.2003.07289.x
Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA: Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004, 65: 1357-1365. 10.1111/j.1523-1755.2004.00512.x
Tetta C, Gianotti L, Cavaillon JM, Wratten ML, Fini M, Braga M, Bisagni P, Giavaresi G, Bolzani R, Giardino R: Coupled plasma filtration adsorption in a rabbit model of endotoxic shock. Crit Care Med 2000, 28: 1526-1533. 10.1097/00003246-200005000-00045
Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002, 30: 1250-1255. 10.1097/00003246-200206000-00015
Mizuno S, Nakamura T: Prevention of neutrophil extravasation by Hepatocyte Growth Factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys. Am J Pathol 2005, 166: 1895-1905.
Cunningham PN, Wang Y, Guo R, He G, Quigg RJ: Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 2004, 172: 2629-2635.
van Griensven M, Probst C, Müller K, Hoevel P, Pape HC: Leukocyte-endothelial interaction via ICAM-1 are detrimental in polymicrobial sepsis. Shock 2006, 25: 254-259. 10.1097/01.shk.0000196497.49683.13
Wu X, Guo R, Wang Y, Cunningham PN: The role of ICAM-1 in endotoxin-induced acute renal failure. Am J Physiol Renal Physiol 2007, 293: F1262-F1271. 10.1152/ajprenal.00445.2006
Gold JA, Parsey M, Hoshino Y, Hoshino S, Nolan A, Yee H, Tse DB, Weiden MD: CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity. Infect Immun 2003, 71: 3521-3528. 10.1128/IAI.71.6.3521-3528.2003
Pontrelli P, Ursi M, Ranieri E, Capobianco C, Schena FP, Gesualdo L, Grandaliano G: CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. J Am Soc Nephrol 2006, 17: 627-636. 10.1681/ASN.2005020202
Castellano G, Cappiello V, Fiore N, Pontrelli P, Gesualdo L, Schena FP, Montinaro V: CD40 ligand increases complement C3 secretion by proximal tubular epithelial cells. J Am Soc Nephrol 2005, 16: 2003-2011. 10.1681/ASN.2002120972
Inwald DP, Faust SN, Lister P, Peters MJ, Levin M, Heyderman R, Klein NJ: Platelet and soluble CD40L in meningococcal sepsis. Intensive Care Med 2006, 32: 1432-1437. 10.1007/s00134-006-0250-2
van Kooten C, Woltman AM, Daha MR: Immunological function of tubular epithelial cells: the functional implications of CD40 expression. Exp Nephrol 2000, 8: 203-207. 10.1159/000020669
Hotchkiss RS, Nicholson DW: Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006, 6: 813-822. 10.1038/nri1943
Zanotti-Cavazzoni SL, Hollenberg SM: Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care 2009, 15: 392-397. 10.1097/MCC.0b013e3283307a4e
Stromberg PE, Woolsey CA, Clark AT, Clark JA, Turnbull IR, McConnell KW, Chang KC, Chung CS, Ayala A, Buchman TG, Hotchkiss RS, Coopersmith CM: CD4+ lymphocytes control gut epithelial apoptosis and mediate survival in sepsis. FASEB J 2009, 23: 1817-1825. 10.1096/fj.08-119024
Langenberg C, Bagshaw SM, May CN, Bellomo R: The histopathology of septic acute kidney injury: a systematic review. Crit Care 2008, 12: R38. 10.1186/cc6823
Lameire N: The pathophysiology of acute renal failure. Crit Care Clin 2005, 21: 197-210. 10.1016/j.ccc.2005.01.001
Glynne PA, Evans TJ: Inflammatory cytokines induce apoptotic and necrotic cell shedding from human proximal tubular epithelial cell monolayers. Kidney Int 1999, 55: 2573-2597. 10.1046/j.1523-1755.1999.00456.x
Glynne PA, Picot J, Evans TJ: Coexpressed nitric oxide synthase and apical beta (1) integrins influence tubule cell adhesion after cytokine-induced injury. J Am Soc Nephrol 2001, 12: 2370-2383.
Bonventre JV, Weinberg JM: Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003, 14: 2199-2210. 10.1097/01.ASN.0000079785.13922.F6
Zegers MM, O'Brien LE, Yu W, Datta A, Mostov KE: Epithelial polarity and tubulogenesis in vitro. Trends Cell Biol 2003, 13: 169-176. 10.1016/S0962-8924(03)00036-9
Fink MP, Delude RL: Epithelial barrier dysfunction: A unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 2005, 21: 177-196. 10.1016/j.ccc.2005.01.005
Lee DB, Huang E, Ward HJ: Tight junction biology and kidney dysfunction. Am J Physiol Renal Physiol 2006, 290: F20-F34. 10.1152/ajprenal.00052.2005
Han X, Fink MP, Delude RL: Proinflammatory cytokines cause NO-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 2003, 19: 229-237. 10.1097/00024382-200303000-00006
Han X, Fink MP, Uchiyama T, Yang R, Delude RL: Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol Lung Cell Mol Physiol 2004, 286: L259-L267. 10.1152/ajplung.00187.2003
Han X, Fink MP, Uchiyama T, Yang R, Delude RL: Increased iNOS activity is essential for hepatic epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol Gastrointest Liver Physiol 2004, 286: G126-G136. 10.1152/ajpgi.00231.2003
Yew WS, Pal SK: Correlation of microalbuminuria and outcome in patients with extensive burns. Br J Anaesth 2006, 97: 499-502. 10.1093/bja/ael211
Molnár Z, Szakmány T, Heigl P: Microalbuminuria does not reflect increased systemic capillary permeability in septic shock. Intensive Care Med 2003, 29: 391-395. 10.1007/s00134-003-1818-8
Christensen EI, Birn H: Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol 2001, 280: F562-F573.
Leheste JR, Rolinski B, Vorum H, Hilpert J, Nykjaer A, Jacobsen C, Aucouturier P, Moskaug JO, Otto A, Christensen EI, Willnow TE: Megalin knockout mice as an animal model of low molecular weight proteinuria. Am J Pathol 1999, 155: 1361-1370.
This work was supported by the Italian Ministry of University and Research (MIUR) PRIN and ex-60%, by Regione Piemonte integrated projects.
CT is a full-time employee of Fresenius Medical Care Deutschland GmbH. The Company will neither gain nor lose from the publication of this manuscript at present or in the future.
Until November 2002, CT was a full-time employee of Bellco S.p.A that owns the herein cited patent of which Ciro Tetta, Mary Lou Wratten and Luisa Sereni are the inventors "wo99109637 1-2305: Method for extracorporeal removal of toxins in particular cytokines, particularly for treating patients affected with acute organ failure". Bellco S.p.A. commercialyzes an extracorporeal device based on this patent, named as coupled plasma filtration adsorption (CPFA). Bellco S.p.A. could neither lose or gain if this manuscript is published because the adsorption material is different from the commercialized one.
The other authors declare that they have no competing interests.
VC and CT conceived the study, analyzed and interpreted the data and elaborated the manuscript. MDC, DC and CR performed the enrollment of patients in the study and carried out the analysis of clinical and biochemical parameters. VW and CT established the in vitro model of resin adsorption and performed the dynamic tests on cytokine removal. VC, CL, FF and SB established the in vitro model of tubular cell injury and performed the in vitro assays. LB developed the plasmid vectors used in the study. LB, CR and GPS participated in the design of the study and in the interpretation of the results. GC conceived and supervised the study, analyzed and interpreted the data and corrected the final version of the manuscript. All authors read and approved the final version of the manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Cantaluppi, V., Weber, V., Lauritano, C. et al. Protective effect of resin adsorption on septic plasma-induced tubular injury. Crit Care 14, R4 (2010). https://doi.org/10.1186/cc8835
- Human Umbilical Vein Endothelial Cell
- Acute Kidney Injury
- Sequential Organ Failure Assessment
- Tubular Epithelial Cell
- Transepithelial Electrical Resistance